Yongnian Liu

826 citations
33 papers · 591 indexed · h-index 15

Yongnian Liu

32 papers receiving 587 citations

Peers

Yongnian Liu
Comparison fields: 5 of 84
  • Immunology 259
  • Hematology 71
  • Cancer Research 67
  • Molecular Biology 300
  • Molecular Medicine 21
Replace Guoqing Hou with:
Guoqing Hou United States
Florian Loher Germany
Su‐Jin Yoo South Korea
Dayuan Zou China
Mengtao Cao China
Yaxiong Deng China
Junhui Yu China
Qiwang Lin China
Terukazu Tanaka Japan
Xiaojing An China
Yongnian Liu relative to Guoqing Hou United States Guoqing Hou's profile →
Citations per field
00.5×3.5×
Guoqing Hou · 1×
Citations per year

Countries citing papers authored by Yongnian Liu

Since Specialization
Citations

This map shows the geographic impact of Yongnian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongnian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongnian Liu more than expected).

Fields of papers citing papers by Yongnian Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongnian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongnian Liu. The network helps show where Yongnian Liu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yongnian Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yongnian Liu Line = papers co-authored together Yongnian Liu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20225
2 20225
3 20226
4
Associations between NKX2-5 gene polymorphisms and congenital heart disease in the Chinese Tibetan population.
20222
5 202121
6 202114
7 20213
8 202119
9 202019
10 201948
11 20191
12 20188
13 201793
14 20174
15 20162
16 201615
17 201542
18 20129
19
Effects of adverse environments on temporal expression pattern of soybean abscission cellulose gene
20061
20
Comparative study of the responsiveness of pulmonary artery between yaks and cows
19951

About Yongnian Liu

Yongnian Liu is a scholar working on Immunology, Cancer Research and Transplantation, having authored 33 papers that have together received 591 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (6 papers), MicroRNA in disease regulation (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), T-cell and B-cell Immunology (4 papers), CAR-T cell therapy research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Immunology (259 citations), Hematology (71 citations) and Cancer Research (67 citations). Yongnian Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shan He, Yi Zhang, Kazuhiro Mochizuki, Shin Mineishi, Qing Tong, Izumi Mochizuki, Hongxing Sun, Ran Reshef, Lijun Meng and Janaki Purushe. Their work appears in journals such as Nature Communications, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026